Breast Cancer FemalesNCT07434817
Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment
A study testing Sexual Health Educational Video Series in people with Breast Cancer Females and Newly Diagnosed Breast Cancer, run by University of Colorado, Denver at 4 sites in United States.
Trial summary
Approximately 200 English- or Spanish-speaking women newly diagnosed with stage I-III breast cancer will be randomized to either receive access to an online sexual health video series or receive usual care. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Breast Cancer Females, Newly Diagnosed Breast Cancer
- What is being tested?
- Sexual Health Educational Video Series
- Type of treatment
- Pill or oral medicine, Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 200 participants
- Where
- 4 sitesUnited States
- Study dates
- 14 Aug 2026to Jan 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Provision to sign and date the consent form.
- Stated willingness to comply with all study procedures and be available for the duration of the study.
- Age minimum 18
- Be a female as assigned on birth certificate
- Ability to read and speak English or Spanish
- A recent diagnosis of Stage 1-III invasive breast cancer and receiving treatment for breast cancer at the University of Colorado or Denver Health breast center(s).
Who cannot join
- Age less than 18 years old
- Stage 0 or Stage IV breast cancer
- Prior breast cancer diagnosis
- Non-breast cancer diagnoses
- Prior exposure to anti-hormone therapy, chemotherapy, or radiotherapy not related to breast cancer
Trial locations and contacts
4 sites in 1 country. Contact the study team or a site near you to ask about taking part.
United States4 sites, 4 recruiting
- Recruiting
University of Colorado Hospital
Aurora, Colorado, 80045
Sarah Leslie, MPH, Sarah.Leslie@cuanschutz.edu
Sarah Tevis, MD
- Recruiting
Denver Health Hospital and Clinic
Denver, Colorado, 80204
Sarah Leslie, MPH, Sarah.Leslie@cuanschutz.edu
Sarah Tevis, MD
- Recruiting
UCHealth Cherry Creek Medical Center
Denver, Colorado, 80206
Sarah Leslie, MPH, Sarah.Leslie@cuanschutz.edu
Sarah Tevis, MD
- Recruiting
UCHealth Highlands Ranch Hospital
Highlands Ranch, Colorado, 80129
Sarah Leslie, MPH, Sarah.Leslie@cuanschutz.edu
Sarah Tevis, MD
About this study
Official title: Improving Breast Cancer Patients' Self-Efficacy and Sexual Health Quality of Life
Approximately 200 English- or Spanish-speaking women newly diagnosed with stage I-III breast cancer will be randomized to either receive access to an online sexual health video series or receive usual care. Participants will complete surveys at baseline and every two months for six months, measuring self-efficacy in patient-provider communication and perceived barriers to discussing sexual health. Electronic health record review will assess utilization of sexual-health-related medical and supportive services. A subset of participants will participate in qualitative interviews to explore their sexual health experiences during treatment and, for those receiving the intervention, the perceived impact of the videos.
- Being tested
- Sexual Health Educational Video Series, Standard Care (in control arm)
- Keywords
- English and Spanish Speaking
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sexual Health Educational Video SeriesBehavioural
Participants randomized to the intervention arm will receive multiprong access to the videos, including a link provided through email and the recruitment sites' patients portal, a QR code, and tablets available in each clinic.
Standard Care (in control arm)Other
Standard Care
| Study group | Role | What they receive |
|---|---|---|
| Intervention Arm | Experimental | Participants receive access to the sexual-health educational video series. Receives: Behavioral: Sexual Health Educational Video Series |
| Control Arm | Placebo comparator | Participants receive standard care Receives: Other: Standard Care (in control arm) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Participant self-efficacy discussing sexual health with breast cancer providers
Changes in participant self-efficacy to discuss sexual health with breast cancer providers will be assessed using the Perceived Efficacy in Patient-Physician Interactions (PEPPI-5), administered at enrollment and every two months over a six-month period. The PEPPI-5 is a 5-item measure scored on a 5-point Likert scale, with higher scores indicating greater perceived self-efficacy in communicating with healthcare providers.
Measured: Baseline, 2 months, 4 months, 6 months
Perceived barriers to discussing sexual health with breast cancer providers
Measured using the 13-item Barriers to Sexual Health Communication (BSHC) scale. Items are rated on a 5-point Likert scale; higher scores reflect greater perceived communication barriers.
Measured: Baseline, 2 months, 4 months, 6 months
Secondary outcomes (2)
Use of medical and supportive services outside of treatment-plan related visits
Participant use of medical and supportive services outside of treatment-plan-related visits will be assessed through electronic health record review from enrollment through 12 months of follow-up. Services of interest will include supportive care, behavioral health, sexual health, rehabilitation, and other ancillary services. Self-reported data collected at enrollment will capture utilization of relevant medical and supportive services in the period prior to study participation.
Measured: 12 months
Qualitative measure: Patient-reported experiences with sexual health and perceived impact of the video content.
Patient sexual health will be assessed qualitatively through semi-structured interviews with a subset of participants at six months following breast cancer diagnosis. Interviews will explore participants' experiences with sexual health concerns and evaluate how the video content did or did not influence their knowledge, communication, coping, and perceived support related to sexual health during treatment and survivorship.
Measured: One time, 60 minute interview, 6-12 months after enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Feb 2026
- Study start14 Aug 2026
- Primary completionJan 2028 (estimated)
- Study completionJan 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast Cancer FemalesStudies of the same condition, open and under way.
- More trials run by University of Colorado, DenverThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Colorado, Denver
- Sponsor type
- University, hospital or other
- Collaborators
- Cancer League of Colorado
- Responsible party
- Sponsor
- Investigators
- Sarah Tevis, Principal investigator, University of Colorado, Denver
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07434817
- Sponsor's protocol ID
- 25-2154.cc
- Status last verified
- Oct 2026
- First submitted
- 19 Feb 2026
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Improving Breast Cancer Patients' Self-Efficacy and Sexual Health Quality of Life
- ClinicalTrials.gov ID
- NCT07434817
- Acronym / sponsor ID
- 25-2154.cc
- Keywords
- English and Spanish Speaking
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- University of Colorado, DenverUniversity, hospital or other
- Collaborators
- Cancer League of Colorado
- Study start
- 14 Aug 2026 (actual)
- Primary completion
- Jan 2028 (estimated)
- Study completion
- Jan 2028 (estimated)
- First posted
- 27 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Approximately 200 English- or Spanish-speaking women newly diagnosed with stage I-III breast cancer will be randomized to either receive access to an online sexual health video series or receive usual care. Participants will complete surveys at baseline and every two months for six months, measuring self-efficacy in patient-provider communication and perceived barriers to discussing sexual health. Electronic health record review will assess utilization of sexual-health-related medical and supportive services. A subset of participants will participate in qualitative interviews to explore their sexual health experiences during treatment and, for those receiving the intervention, the perceived impact of the videos.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention Arm | Experimental | Behavioral: Sexual Health Educational Video SeriesParticipants receive access to the sexual-health educational video series. |
| Control Arm | Placebo comparator | Other: Standard Care (in control arm)Participants receive standard care |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Provision to sign and date the consent form.
- Stated willingness to comply with all study procedures and be available for the duration of the study.
- Age minimum 18
- Be a female as assigned on birth certificate
- Ability to read and speak English or Spanish
Key exclusion criteria (5 listed)
- Age less than 18 years old
- Stage 0 or Stage IV breast cancer
- Prior breast cancer diagnosis
- Non-breast cancer diagnoses
- Prior exposure to anti-hormone therapy, chemotherapy, or radiotherapy not related to breast cancer
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sexual Health Educational Video SeriesParticipants randomized to the intervention arm will receive multiprong access to the videos, including a link provided through email and the recruitment sites' patients portal, a QR code, and tablets available in each clinic. | Behavioural | Intervention Arm |
| Standard Care (in control arm)Standard Care | Other | Control Arm |
Primary outcome
Participant self-efficacy discussing sexual health with breast cancer providers
Time frame: Baseline, 2 months, 4 months, 6 months
Changes in participant self-efficacy to discuss sexual health with breast cancer providers will be assessed using the Perceived Efficacy in Patient-Physician Interactions (PEPPI-5), administered at enrollment and every two months over a six-month period. The PEPPI-5 is a 5-item measure scored on a 5-point Likert scale, with higher scores indicating greater perceived self-efficacy in communicating with healthcare providers.
Perceived barriers to discussing sexual health with breast cancer providers
Time frame: Baseline, 2 months, 4 months, 6 months
Measured using the 13-item Barriers to Sexual Health Communication (BSHC) scale. Items are rated on a 5-point Likert scale; higher scores reflect greater perceived communication barriers.
2 secondary outcomes
Use of medical and supportive services outside of treatment-plan related visits
Time frame: 12 months
Qualitative measure: Patient-reported experiences with sexual health and perceived impact of the video content.
Time frame: One time, 60 minute interview, 6-12 months after enrollment
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Oct 2026.
Related trials for Breast Cancer Females
Recruiting
Decision Support for Chemoprevention
Breast Cancer
Not yet recruiting
Geriatric Oncology Assessment and Coping Skills Training for Older Women on Aromatase Inhibitor Therapy
Breast Cancer, Hormone Receptor Positive, Aromatase Inhibitor-Associated Arthralgia
Recruiting
The Vanguard Study: Testing a New Way to Screen for Cancer
Bladder Carcinoma, Breast Carcinoma
Active, not recruitingPhase 1
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Advanced Solid Tumor
RecruitingPhase 1
A Phase I Study of CG-7321 Monotherapy or Combination Therapy in Advanced Solid Tumors
Advanced Solid Tumors, Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Sarah Tevis principal investigator
University of Colorado, Denver
4 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Sexual Health Educational Video Series in people with Breast Cancer Females and Newly Diagnosed Breast Cancer, run by University of Colorado, Denver at 4 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 22 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Sarah Leslie, MPH (303-724-8995, Sarah.Leslie@cuanschutz.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Participant self-efficacy discussing sexual health with breast cancer providers (time frame: Baseline, 2 months, 4 months, 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2026.